Medicare Enrolled

Dr. Sudhisha Jala, PA-C

Medical Physician Assistant · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
980 JOHNSON FERRY RD STE 820, Atlanta, GA 30342
4042529307
In practice since 2017 (8 years)
NPI: 1659895373 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jala? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jala

Dr. Sudhisha Jala is a medical physician assistant in Atlanta, GA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Jala performed 228 Medicare services across 151 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jala received a total of $3,849 from 35 pharmaceutical and/or device companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ 228 Medicare services $3,849 industry payments

Medicare Practice Summary

Medicare Utilization ↗
228
Medicare services
Bottom 45% in GA for medical physician assistant
151
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
154 $53 $210
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
74 $87 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,849
Total received (2021-2024)
Avg $962/year across 4 years
Top 17% in GA for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,832 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,195
2023
$725
2022
$1,032
2021
$896

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$191
Janssen Biotech, Inc.
$172
Intercept Pharmaceuticals, Inc.
$145
QOL Medical, LLC
$115
Ardelyx, Inc.
$98
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$87
PFIZER INC.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$61
Regeneron Healthcare Solutions, Inc.
$51
Organon Llc
$38
Gilead Sciences, Inc.
$30
Sandoz Inc.
$27
GENZYME CORPORATION
$25
IRONWOOD PHARMACEUTICALS, INC
$19
Fresenius Kabi USA, LLC
$18
Madrigal Pharmaceuticals
$18
EVOKE PHARMA, INC.
$14
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$694
Takeda Pharmaceuticals U.S.A., Inc.
$520
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$485
Janssen Biotech, Inc.
$335
AbbVie Inc.
$230
Intercept Pharmaceuticals, Inc.
$145
Ardelyx, Inc.
$116
QOL Medical, LLC
$115
Regeneron Healthcare Solutions, Inc.
$106
GENZYME CORPORATION
$105
BOSTON SCIENTIFIC CORPORATION
$104
Boston Scientific Corporation
$91
PFIZER INC.
$86
Ironwood Pharmaceuticals, Inc
$77
Nestle HealthCare Nutrition Inc.
$65
Merck Sharp & Dohme LLC
$62
RedHill Biopharma Inc.
$56
Sandoz Inc.
$49
Daiichi Sankyo Inc.
$43
Organon Llc
$38
SANOFI-AVENTIS U.S. LLC
$36
Fresenius Kabi USA, LLC
$36
Gilead Sciences, Inc.
$30
Lilly USA, LLC
$25
Amgen Inc.
$23
E.R. Squibb & Sons, L.L.C.
$22
Micro-tech Endoscopy USA, Inc.
$19
IRONWOOD PHARMACEUTICALS, INC
$19
AIMMUNE THERAPEUTICS, INC.
$18
Ethicon US, LLC
$18
Madrigal Pharmaceuticals
$18
VIVUS LLC
$17
Celgene Corporation
$16
Celltrion USA Inc.
$16
EVOKE PHARMA, INC.
$14
Top 3 companies account for 44.1% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Aemcolo · CREON · DIFICID · DUPIXENT · ENTYVIO · EXALT · EXALT Model D · Epclusa · GATTEX · GIMOTI · HADLIMA · HUMIRA · HYRIMOZ · IBSRELA · IDACIO · INJECTAFER · LINZESS · Linzess · MAVYRET · MOTEGRITY · OCALIVA · QSYMIA · RENFLEXIS · RESMETIROM · REZUROCK · RINVOQ · SKYRIZI · STELARA · SUCRAID · SureClip · TREMFYA · TRULANCE · Talicia · VELSIPITY · VIBERZI · VOWST · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical physician assistant in Atlanta?
Compare medical physician assistants in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants within 10 mi
648
Per 100K population
60.6
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jala is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jala experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Jala performed 154 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jala receive payments from pharmaceutical companies?
Yes. Dr. Jala received a total of $3,849 from 35 companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jala's costs compare to other medical physician assistants in Atlanta?
Dr. Jala's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →